Brought to you by 
Merck KGAA to buy 42% of Pharmaceutical Resources
06 Apr 2001
Executive Summary
Merck KGAA has agreed to acquire, through its subsidiary Lipha, a 42% share in the US drug manufacturer Pharmaceutical Resources for about $20.8mm (DM45mm). It also gets exclusive US marketing rights to 40 generic products.
Deal Industry
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Merck KGAA to buy 42% of Pharmaceutical Resources
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice